2022年12月12日

波士頓(BUSINESS WIRE) -提供虛擬優先護理(V1C)的數字健康創新者nuvoair今天宣布任命兩位行業領導者為其董事會成員。傑出的醫療保健高管Karen Piacentini和Alexander Packard帶來了擴展技術支持的醫療保健組織的長期經驗。NuvoAir很高興將這些成員的專業知識加入到現有董事會的強大基礎中，因為公司進入了支持基於價值的護理模式的下一個增長階段。“隨著我們的發展，我們歡迎新董事會成員的加入，以使健康計劃和負責任的醫療組織(ACOs)能夠為被診斷患有慢性阻塞性肺病(COPD)和慢性心力衰竭(CHF)等最複雜和最昂貴疾病的成員提供虛擬優先護理。鑒於三分之一的COPD患者同時患有CHF，住院和死亡的風險增加了30%，美國的付款人比以往任何時候都更關注心肺疾病。引進Karen和Alexander的人才將提高我們徹底改變護理體驗的能力，”NuvoAir創始人兼首席執行官Lorenzo Consoli說。Karen Piacentini是一位以結果為導向的醫療保健高管和顧問，擁有30年的醫療計劃管理經驗。作為Optum的高級副總裁，Karen確保了Optum和UnitedHealthcare的目標和戰略一致，在優化運營效率的同時推動了顯著的增長。在加入Optum之前，Karen領導了UnitedHealthcare雇主和個人產品戰略，並推動了每年超過45個新產品的創新管道。她曾在信諾(Cigna)、保誠(Prudential)和哥倫比亞大學(Columbia University)擔任高管職位。 “Health plans realize there is a massive opportunity to capitalize on innovations in high-cost areas such as COPD, especially when comorbidities such as chronic heart failure augment the complexities of patient engagement and the ability to deliver effective care management. I look forward to working with NuvoAir to help align payor needs with our solutions within value-based care arrangements,” states Karen Piacentini. Alexander Packard is a strategic advisor and executive coach at Harvard Business School with 25 years of experience scaling innovative companies. As a founding team member and former COO and President of Iora Health, he helped to build and nationally scale their value-based primary care delivery model. He joined One Medical as Chief Integration Officer to ensure a successful merger when One Medical acquired Iora Health in 2021. Over the last two decades, Alexander has coached and advised leaders at both for-profit and nonprofit organizations. Alexander Packard states, “I’m excited to join NuvoAir at this stage as the company has begun to realize meaningful gains for those living with cardio-pulmonary conditions. NuvoAir’s model is robust and built on a bespoke engagement engine that allows risk-bearing providers and payors to reach those diagnosed with costly conditions who have traditionally been difficult to engage or have limited access to specialty care. NuvoAir is flipping the script on care delivery and these are exciting times.” About NuvoAir NuvoAir is a digital health innovator focusing on patients living with cardio-pulmonary conditions such as COPD, CHF, and asthma. NuvoAir offers a virtual-first care (V1C) model that delivers continuous, proactive care by combining best-in-class remote monitoring technology with proprietary biomarkers and deep clinical expertise through an interdisciplinary virtual clinic – all supported by a data-driven infrastructure. NuvoAir works with risk-bearing partners to integrate technology and data to enable personalized care for each member. The patient-centric approach also underlies NuvoAir’s clinical trial solution. For more information, visit www.nuvoair.com .